Human MCP-1, also known as CCL2, is a member of the CC β chemokine family. It is widely expressed in endothelial cells, smooth muscle cells, and monocytes in response to several atherogenic stimulants such as CD40 ligand, platelet derived growth factor (PDGF), interleukin-1β (IL-1β), and oxidized low density lipoprotein. Several recent in vivo studies have disclosed critical roles of MCP-1 in atherosclerosis. In addition, MCP-1 has been implicated in monocytic infiltration of tissues during several inflammatory diseases, and has been implicated in macrophage-mediated tumor growth suppression in mice. Kidney epithelial cells, including glomerular podocytes and tubular cells, make MCP-1 in response to high glucose and advanced glycation end products.
The workflow for the Pu•MA System cytokine immunoassay is shown in the figure below. All assay reagents are prepared in advance and then loaded into Pu•MA System flowchips using single or 8-channel pipettes. The wells are conveniently located on standard 384 multiwell plate spacings. The flowchips are now ready to be loaded into the Pu•MA System for “hands-off” processing. The ELISA steps are automatically performed by the system using pre-loaded protocols. Once the assay is complete, absorbance results are read on your Plate Reader.
- Low-volume assays (10-20 μl)
- Simple “hands-off” operation
- Open platform – no expensive plates
The adaption of existing ELISA kits and/or antibody pairs is straightforward with the Pu•MA System. Assay buffers optimized for the Pu•MA System flowchips are provided for sample and antibody dilutions. Blocking solutions and wash buffers are also provided. The MCP-1 assays are adapted from BioLegend ELISA Max Kits (p/n 438804, 438805, & 438806).
Assay antibody reagents were prepared according to the dilutions shown in the Table using Pu•MA Assay Buffer (PAB). MCP-1 standards were reconstituted according to instructions from BioLegend. A 1:2 serial dilution series of Human MCP-1 Standard was prepared starting at 100 pg/well using PAB. 20 μl of each reagent was added to the appropriate wells (see Fig 3) except for the Stop Solution where 10 μl was dispensed. Four replicates were run per concentration. The flowchips were loaded into a Pu•MA System and processed using the MCP-1 Assay Protocol. Plates were read within 5 minutes of being finished on an absorbance plate reader at 450 nm (Tecan Spectrafluor Plus).
Pu•MA System Human MCP-1 Standard Curve
How It Works
The Pu•MA Flowchip and System uses established antibody pairs to perform an automated ELISA. All assay reagents are loaded into reservoirs and then moved one at a time through the “Assay Channel” by the Pu•MA System. Preloaded protocols execute all fluid transfer and incubation steps. The system incorporates patented valve-less fluidic switching (VLFS) to precisely control fluid movement in a flowchip. Use of microfluidics reduces
both incubation times and reagent volumes.
|Capture Ab||Human MCP-1 ELISA Max Capture
|Block||Pu•MA Blocking Buffer||PFI|
|Sample||Human MCP-1 Standard||BL|
|1°Ab||Human MCP-1 ELISA Max Detection
|Wash||Pu•MA Wash Buffer||PFI|
|Stop||Pu•MA Stop Solution||PFI|
Microfluidic Assay Workflow
- Compact benchtop system
- Easy top-loading of flowchips
- Precision pneumatic control
- Touchscreen-driven interface
- Preloaded assay protocols
- Simple Select and Run operation
Reagents & Flowchips
- Validated immunoassays
- Open platform for existing Ab pairs
- Works with standard pipettors & tips